We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

3 Private Actions Fight AndroGel Reverse Payments

Law360 (February 4, 2009, 12:00 AM EST) -- Three classes of buyers of the testosterone supplement AndroGel have hit several drugmakers with separate actions claiming their patent settlements over the drug thwarted competition and denied the buyers cheaper generics.

Two of the proposed class actions were filed on Tuesday in the U.S. District Court for the Central District of California. The first private action was filed on Monday in the same court, on the same day the state of California and the Federal Trade Commission launched their own suit in that court making similar...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.